Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Federal Trade Commission
Teva
QuintilesIMS
Dow
Mallinckrodt
Chinese Patent Office
Colorcon
Medtronic

Generated: February 20, 2019

DrugPatentWatch Database Preview

Drug Sales Trends for MESALAMINE

« Back to Dashboard

Payment Methods and Pharmacy Types for MESALAMINE (2016)

Revenues by Pharmacy Type

Pharmacy Type Revenues
INSIDE HMO/CLINIC/HOSPITAL $32,581,439
DRUG STORE $30,547,228
[disabled in preview] $0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
INSIDE HMO/CLINIC/HOSPITAL 23,666
DRUG STORE 71,962
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICAID $24,722,679
MEDICARE $5,077,542
[disabled in preview] $33,328,446
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for MESALAMINE
Drug Units Sold Trends for MESALAMINE

Annual Sales Revenues and Units Sold for MESALAMINE

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
MESALAMINE ➤ Try a Free Trial ➤ Try a Free Trial 2016
MESALAMINE ➤ Try a Free Trial ➤ Try a Free Trial 2015
MESALAMINE ➤ Try a Free Trial ➤ Try a Free Trial 2014
MESALAMINE ➤ Try a Free Trial ➤ Try a Free Trial 2013
MESALAMINE ➤ Try a Free Trial ➤ Try a Free Trial 2012
MESALAMINE ➤ Try a Free Trial ➤ Try a Free Trial 2011
MESALAMINE ➤ Try a Free Trial ➤ Try a Free Trial 2010
Drug Name Revenues (USD) Units Year

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
US Department of Justice
Baxter
US Army
Healthtrust
Citi
AstraZeneca
Covington
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.